首页|鼻胰管在重症急性胰腺炎腹腔感染合并胰瘘病人中的应用效果分析

鼻胰管在重症急性胰腺炎腹腔感染合并胰瘘病人中的应用效果分析

扫码查看
目的 探讨鼻胰管在重症急性胰腺炎腹腔感染合并胰瘘病人中的应用效果.方法 回顾性分析武汉大学人民医院胰腺外科2019年6月至2021年1月期间收治的47例重症急性胰腺炎腹腔感染合并胰瘘病人的临床资料,根据病人是否经过内镜逆行胰胆管造影(endoscopic retrograde cholangiopancreatography,ERCP)留置鼻胰管分为两组:研究组(22例)和对照组(25例),研究组病人ERCP术中置入鼻胰管,对照组不放置鼻胰管,仅常规经皮穿刺置管引流术(percutaneous catheter drainage,PCD)操作,分析其术后疗效.结果 研究组在经ERCP介导下行鼻胰管引流,研究组带管时间为(12.10±5.89)d,对照组带管时间为(17.90±3.95)d,与对照组比较,研究组腹腔引流管带管时间显著减少(P<0.05);且治疗期间以下指标均明显下降:脓毒症发生率[研究组4.5%(1/22),对照组32.0%(8/25)],腹腔出血(需要介入或手术干预的活动性出血)发生率[研究组4.5%(1/22),对照组28.0%(7/25)],假性囊肿发生率[研究组13.6%(3/22),对照组40.0%(10/25)],差异均具有统计学意义(均P<0.05);而白细胞升高持续时间和住院时间两组间差异均无统计学意义(均P>0.05).结论 重症急性胰腺炎腹腔感染合并胰瘘的病人可以考虑行鼻胰管置入减少胰瘘量、控制腹腔感染,从而减少病情进展为难治性胰瘘,降低胰腺假性囊肿、大量出血等严重并发症的发生率,减少病人带管时间,其应用具有一定的临床价值.
Application outcomes of naso-pancreatic duct in patients with severe acute pancreatitis intraperitoneal infection complicated with pancreatic fistula
Objective To explore the application outcomes of naso-pancreatic duct in patients with intraperitoneal infection of severe acute pancreatitis complicated with pancreatic fistula.Methods From June 2019 to January 2021,the relevant clinical data were retrospectively reviewed for 47 patients with intraperitoneal infection of severe acute pancreatitis plus pancreatic fistula.They were assigned into two groups of treatment(n=22)and control(n=25).Treatment group had an insertion of a naso-pancreatic duct during endoscopic retrograde cholangiopancreatography(ERCP)while control group was not placed.Postoperative efficacy was examined.Results As compared with control group,study group underwent nasal pancreatic duct drainage via ERCP for(12.10±5.89)days.And indwelling time of control group was(17.90±3.95)days.Abdominal drain had markedly reduced indwelling time,And sepsis during treatment occurred at a rate of 4.5%(1/22)in study group and a rate of 32.0%(8/25)in control group.The incidence of active abdominal hemorrhage requiring intervention or surgical intervention was 4.5%(1/22)in study group and 28.0%(7/25)in control group.And pseudocysts occurred at a rate of 13.6%(3/22)in study group and a rate of 40.0%(10/25)in control group.All differences were statistically significant(all P<0.05),However,no significant difference existed in duration of leucocytosis or length of hospitalization(P>0.05).Conclusion For patients with severe intraperitoneal infection of acute pancreatitis complicated with pancreatic fistula,naso-pancreatic duct implantation may minimize the amount of pancreatic fistula and control abdominal infection,thereby arresting the progression of the disease to refractory pancreatic fistula and the occurrence of serious complications such as pancreatic pseudocyst and massive bleeding.It can reduce the time of patients with tube,and its application has certain clinical value.

Severe acute pancreatitisIntraperitoneal infectionPancreatic fistulaNaso-pancreatic ductEndoscopic retrograde cholangiopancreatography

朱孔凡、朱忠超、李蔚、常剑

展开 >

武汉大学人民医院胰腺外科,湖北 武汉 430060

重症急性胰腺炎 腹腔感染 胰瘘 鼻胰管 内镜逆行胰胆管造影

2024

腹部外科
中华医学会武汉分会

腹部外科

CSTPCD
影响因子:0.615
ISSN:1003-5591
年,卷(期):2024.37(1)
  • 9